Weight Loss treatments
for every budget
Find The Right Plan That Works For You.
Fast, Affordable, and Effective.
Start my visit
GET UP TO 6 MONTH GLP-1 SUPPLIES
WITH 4 INTEREST-FREE PAYMENTS
How much do you weigh?
160
lbs
You could lose
30
lbs
The Lipo Rx Guarantee: Lose 10% Of Your Body Weight In 4 Months Or Your Money Back!
Your Path to Healthy Weight Starts Here
Weight Loss Treatments in 3 Easy Steps
1
Take Our Free 2-Minute Questionnaire
Answer a brief questionnaire and we’ll connect you to a Lipo RX doctor.
2
A doctor will review your answers in 24 hours
Receive a personalized weight loss
treatment reviewed by our medical team.
3
Free Expedited Delivery to Your Doorstep
Medication delivered to your door in as little as 3 Days from signup.
GLP-1 MEDICATIONS TAILORED TO YOU, DELIVERED TO YOUR DOOR
Start my visit
50+
Years of
Experience
~15-22%
reduction IN
BODY WEIGHT*
(2022 - New England Journal of Medicine)
*2022 Clinical Study: “Tirzepatide Once Weekly for the
Treatment of Obesity” | New England Journal of Medicine
Lose Weight With GLP-1 Medications
People are talking because it works.
Semaglutide is a prescription medication that is prescribed for weight loss and Type 2 Diabetes. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. It mimics the action of GLP-1, a hormone that stimulates the release of insulin and reduces the amount of glucose produced by the liver. This helps lower blood sugar levels in people with diabetes.
Semaglutide also reduces the speed at which food passes through the digestive system. Semaglutide prolongs digestion, helping to maintain your feeling of fullness for a longer period. Therefore, when you take Semaglutide injections, you feel fuller faster and are less likely to overeat.
Semaglutide and Tirzepatide prolong digestion,
Helping to maintain your feeling of fullness for a longer period.
Testimonials
Why Our Patients Trust Lipo RX
GLP-1 medications like Semaglutide and Tirzepatide have been shown to help with significant weight loss, but results vary based on factors like dosage, diet, exercise, and individual response. Clinical trials show an average weight loss of 15-22% over 6-12 months.
Pay in 4 from
Enjoy Now, Pay Later
Just choose “PAY LATER” at checkout and split your payments in 4.
It’s interest free, has no impact on your credit score and is backed by PayPal.
Start my visit
Understanding GLP-1 Weight Loss Treatments
Semaglutide vs Tirzepatide: How Do They Compare?
While both medications effectively aid in weight loss for most patients, certain differences may influence which option is best for an individual.
Mechanism of Action:
- Semaglutide: Functions solely as a GLP-1 receptor agonist, reducing hunger and food cravings.
- Tirzepatide: Acts on both GLP-1 and GIP receptors, enhancing appetite suppression more than semaglutide alone.
Efficacy:
- Blood Sugar Control: Clinical trials indicate that tirzepatide lowers HbA1c (a key marker of blood glucose levels) more effectively than semaglutide.
- Weight Loss: Tirzepatide (studied as Zepbound) has demonstrated greater weight loss compared to semaglutide (FDA-approved as Wegovy), making it a compelling option for weight management.
Possible Side Effects:
- Both medications may cause gastrointestinal side effects, such as nausea, vomiting, and diarrhea, though their severity varies among individuals.
- Due to its dual-action mechanism, tirzepatide may have a distinct side effect profile. Notably, it has been associated with fewer gastrointestinal side effects (such as nausea and vomiting) compared to semaglutide, despite leading to greater weight loss over time.
Features
Semaglutide
(Name Brands: Ozempic, Wegovy)
Tirzepatide
(Name Brands: Mounjaro, Zepbound)
Drug Class
GLP-1 receptor agonist
Dual GLP-1 & GIP receptor agonist
Mechanism of Action
Reduces hunger, slows digestion, enhances insulin secretion
Enhances GLP-1 effects and boosts insulin sensitivity via GIP activation
FDA Approval
Ozempic (2017, Type 2 Diabetes), Wegovy (2021, Obesity)
Mounjaro (2022, Type 2 Diabetes), Zepbound (2023, Obesity)
Weight Loss
~15% of body weight (Wegovy trials)
~22% of body weight (Zepbound trials)
A1C Reduction
~1.5% to 2.1%
~2.0% to 2.5%
Dosing
Weekly injection (0.25 mg to 2.4 mg)
Weekly injection (2.5 mg to 15 mg)
Side Effects
Nausea, vomiting, diarrhea, constipation
Nausea, diarrhea, less vomiting than semaglutide
Cardiovascular Benefits
Proven to reduce heart attack and stroke risk
Ongoing studies on cardiovascular effects
Pancreatitis Risk
Yes (rare)
Yes (rare)
Availability
Ozempic, Wegovy
Mounjaro, Zepbound
Out-of-Pocket Cost
$900 - $1,500 *According to GoodRX
$1,000 - $1,200 *According to GoodRX
Key Takeaways:
Tirzepatide shows greater weight loss and A1C reduction due to its dual action.
Semaglutide has well-established cardiovascular
benefits, while tirzepatide's effects in this area are still under study.
Tirzepatide may be effective in reducing alcohol consumption and providing treatment for other forms of addiction.*
Side effects are similar, but
tirzepatide may cause less vomiting while still being more effective
for weight loss.
Source: (Sci Rep, “Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity”, Nov 2023)
Proudly Serving Patients Nationwide From Local FDA Approved Pharmacies
*Service not available in the following states: Louisiana and Mississippi.
*Also available in Puerto Rico.